Valsartan Solution
NDC Package 70954-310-10
Package Information
Valsartan solution is valsartan is used to treat high blood pressure and heart failure. This formulation utilizes a solution delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 70954-310 and is authorized under FDA application ANDA214102.
Identification & Billing
- RxCUI: 1996254 - valsartan 20 MG in 5 mL Oral Solution
- RxCUI: 1996254 - valsartan 4 MG/ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70954 - Ani Pharmaceuticals, Inc.
- 70954-310 - Valsartan
- 70954-310-10 - 120 mL in 1 BOTTLE, PLASTIC
- 70954-310 - Valsartan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70954-310). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70954-310-10 identifies a specific commercial package of 120 ml in 1 bottle, plastic of Valsartan, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 120 billable units per package. This solution is formulated for oral use and contains valsartan as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on November 02, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Valsartan is used to treat high blood pressure and heart failure. It is also used to improve the chance of living longer after a heart attack. In people with heart failure, it may also lower the chance of having to go to the hospital for heart failure. Valsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.
How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70954031010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.